Schulz G - Search Results

1

Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, nonconcentrated vector-containing medium.

Glimm H, Flügge K, Möbest D, Hofmann VM, Postmus J, Henschler R, Lange W, Finke J, Kiem HP, Schulz G, Rosenthal F, Mertelsmann R, von Kalle C. Glimm H, et al. Among authors: schulz g. Hum Gene Ther. 1998 Apr 10;9(6):771-8. doi: 10.1089/hum.1998.9.6-771. Hum Gene Ther. 1998. PMID: 9581900

2

Umbilical cord blood: an alternative to the transplantation of bone marrow stem cells.

Weber-Nordt RM, Schott E, Finke J, Henschler R, Schulz G, Mertelsmann R. Weber-Nordt RM, et al. Among authors: schulz g. Cancer Treat Rev. 1996 Sep;22(5):381-91. doi: 10.1016/s0305-7372(96)90010-9. Cancer Treat Rev. 1996. PMID: 9118123 Review.

3

New developments in hematopoietic stem cell expansion.

von Kalle C, Glimm H, Schulz G, Mertelsmann R, Henschler R. von Kalle C, et al. Among authors: schulz g. Curr Opin Hematol. 1998 Jan;5(1):79-86. doi: 10.1097/00062752-199801000-00013. Curr Opin Hematol. 1998. PMID: 9515207 Review.

4

Good manufacturing practice production of human stem cells for somatic cell and gene therapy.

Bosse R, Singhofer-Wowra M, Rosenthal F, Schulz G. Bosse R, et al. Among authors: schulz g. Stem Cells. 1997;15 Suppl 1:275-80. doi: 10.1002/stem.5530150835. Stem Cells. 1997. PMID: 9368351 Review.

5

Production of stem-cell transplants according to good manufacturing practice.

Bosse R, Kulmburg P, von Kalle C, Engelhardt M, Dwenger A, Rosenthal F, Schulz G. Bosse R, et al. Among authors: schulz g. Ann Hematol. 2000 Sep;79(9):469-76. doi: 10.1007/s002770000176. Ann Hematol. 2000. PMID: 11043417 Review.

6

Hematopoietic growth factors in bone marrow transplantation.

Mertelsmann R, Herrmann F, Hecht T, Schulz G. Mertelsmann R, et al. Among authors: schulz g. Bone Marrow Transplant. 1990 Aug;6(2):73-7. Bone Marrow Transplant. 1990. PMID: 1698494 Review.

7

Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following standard-dose combination chemotherapy with etoposide, ifosfamide, and cisplatin.

Brugger W, Frisch J, Schulz G, Pressler K, Mertelsmann R, Kanz L. Brugger W, et al. Among authors: schulz g. J Clin Oncol. 1992 Sep;10(9):1452-9. doi: 10.1200/JCO.1992.10.9.1452. J Clin Oncol. 1992. PMID: 1517788 Clinical Trial.

8

Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin.

Brugger W, Birken R, Bertz H, Hecht T, Pressler K, Frisch J, Schulz G, Mertelsmann R, Kanz L. Brugger W, et al. Among authors: schulz g. Br J Haematol. 1993 Jul;84(3):402-7. doi: 10.1111/j.1365-2141.1993.tb03093.x. Br J Haematol. 1993. PMID: 7692928

9

Biologic effects of recombinant human interleukin-3 in vivo.

Lindemann A, Ganser A, Herrmann F, Frisch J, Seipelt G, Schulz G, Hoelzer D, Mertelsmann R. Lindemann A, et al. Among authors: schulz g. J Clin Oncol. 1991 Dec;9(12):2120-7. doi: 10.1200/JCO.1991.9.12.2120. J Clin Oncol. 1991. PMID: 1960553 Clinical Trial.

10

Stimulation of granulopoiesis in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor: assessment of two routes of administration.

Herrmann F, Ganser A, Lindemann A, Schulz G, Lübbert M, Hoelzer D, Mertelsmann R. Herrmann F, et al. Among authors: schulz g. J Biol Response Mod. 1990 Oct;9(5):475-9. J Biol Response Mod. 1990. PMID: 2254759 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

836 results

Search Page